Investigation of the in vitro biotransformation of R-(+)-thalidomide by HPLC, nano-HPLC, CEC and HPLC-APCI-MS

Citation
M. Meyring et al., Investigation of the in vitro biotransformation of R-(+)-thalidomide by HPLC, nano-HPLC, CEC and HPLC-APCI-MS, J CHROMAT B, 723(1-2), 1999, pp. 255-264
Citations number
18
Categorie Soggetti
Chemistry & Analysis
Journal title
JOURNAL OF CHROMATOGRAPHY B
ISSN journal
13872273 → ACNP
Volume
723
Issue
1-2
Year of publication
1999
Pages
255 - 264
Database
ISI
SICI code
1387-2273(19990219)723:1-2<255:IOTIVB>2.0.ZU;2-U
Abstract
High-performance liquid chromatography (HPLC), nano-HPLC, capillary electro chromatography (CEC) and on-line HPLC-atmospheric pressure chemical ionizat ion mass spectrometry (APCI-MS) techniques were used for the identification and detailed characterization of two new metabolites of the former sedativ e drug thalidomide (TD). The advantages of nano-HPLC and CEC are higher pea k efficiency and a drastic decrease in the analysis time, which, together w ith lower sample dilution during the analyses, allowed to obtain a detectio n sensitivity that was comparable to HPLC with common-sized columns. Both, nano-HPLC and CEC could be realized in the commercially available capillary electrophoresis system HP3D. On-line HPLC-APCI-MS coupling is a very usefu l technique for the rapid identification of metabolites without any need fo r reference compounds. (C) 1999 Elsevier Science B.V. All rights reserved.